Mohamed Elzubier Elzubier

6PUBLICATIONS
26CO-AUTHORS
Pharmaceutical delivery technologiesToxicology (incl. clinical toxicology)Cancer therapy (excl. chemotherapy and radiation therapy)Natural products and bioactive compoundsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Dec 23, 2023
Improved Glycaemic Control and Nephroprotective Effects of Empagliflozin and Paricalcitol Co-Therapy in Mice with Type 2 Diabetes Mellitus.

Abdulrahman Mujalli, Wesam F Farrash, Ahmad A Obaid

|Nov 24, 2023
Antioxidative and Anti-Inflammatory Protective Effects of Fucoxanthin against Paracetamol-Induced Hepatotoxicity in Rats.

Maimonah Fuad Koshak, Mahmoud Zaki El-Readi, Mohamed Elzubier Elzubier

|Apr 28, 2023
Cymbopogon citratus and Citral Overcome Doxorubicin Resistance in Cancer Cells via Modulating the Drug's Metabolism, Toxicity, and Multidrug Transporters.

Mohammed Hasan Mukhtar, Mahmoud Zaki El-Readi, Mohamed E Elzubier

|Mar 29, 2023
In Vitro Anticancer and Antibacterial Activities of the Essential Oil of Forsskal's Basil Growing in Extreme Environmental Conditions.

Ammar Bader, Ashraf N Abdalla, Najla A Obaid

|Feb 23, 2023
Investigation of Hyperlipidemia Associated with Increased Levels of Oxidized Low-Density Lipoproteins and 8-Hydroxy-2´-Deoxyguanosine.

Abdullatif Babakr, Mohamed Mukhtar, Mohammad Althubiti

|Dec 11, 2022
Evaluation of the Anti-Obesity Effect of Zeaxanthin and Exercise in HFD-Induced Obese Rats.

Mona Al-Thepyani, Salha Algarni, Hana Gashlan

Pageof 1

Frequent Collaborators

3 joint publications

Riyad Adnan Almaimani

3 joint publications

Bassem Refaat

2 joint publications

Mahmoud Zaki El-Readi

2 joint publications

Mohammad Althubiti